Gladstone NOW: The Campaign Join Us on the Journey ✕
31 - 45 of 258 Results Clear All
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, shares his views on the likelihood of a new COVID surge this winter.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
Invisishield Technologies—Gladstone Senior Investigator Warner Greene has been appointed President and Chief Scientific Officer of Invisihield Technologies. Invisishield is focused on developing intranasal preventatives for respiratory viruses, including SARS-CoV-2.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
San Francisco Chronicle—The new bivalent COVID-19 booster shots are recommended for individuals age 5 and up who are at least two months past their last vaccine dose. Gladstone Investigator Nadia Roan explains that the bivalent boosters greatly increase the levels of antibodies that can prevent the Omicron variant from infecting cells.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
San Francisco Chronicle—New COVID-19 booster shots targeting both the ancestral virus and omicron strains are now available. Gladstone Investigator Nadia Roan weighs in on when people should get the jab, based on the timing of their last dose and whether they’ve been recently infected.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
The single-dose, intranasal treatment also reduces symptoms of multiple variants of the SARS-CoV-2 virus
News Release Research (Publication) COVID-19 Center for Cell Circuitry Infectious Disease Weinberger Lab Chaturvedi
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, says that it makes more sense to boost immunity with the newly approved bivalent vaccines targeting Omicron than with vaccines that aim at long-extinct variants of the coronavirus.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
Abdullah Syed, who is researching SARS-CoV-2, shares his passion for bad puns and animal facts, as well as his favorite part of working at Gladstone.
Postdoctoral and Graduate Student Education and Research Development Affairs Postdoc Advisory Committee Graduate Students and Postdocs Profile COVID-19 Doudna Lab
ABC7 News—The federal government plans to roll out a new vaccine against the BA.5 Omicron variant now predominant in the US early this fall. Senior Investigator Warner Greene, MD, PhD, says that you might want to hold off for your next booster shot until you can get this new vaccine, which will offer better protection against currently circulating variants.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
The Daily Californian—Senior Investigator Melanie Ott, MD, PhD, and collaborator Abdullah Syed, PhD, a postdoctoral fellow in the laboratory of Senior Investigator Jennifer Doudna, explain how they discovered that antibodies against early versions of the SARS-CoV-2 virus do not protect well against the now widespread and highly contagious Omicron variant, and recommend masking to avoid new infections.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab
Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodies
News Release Research (Publication) COVID-19 Infectious Disease Doudna Lab Ott Lab
Gladstone researchers find new evidence against using BET inhibitors to treat COVID-19
News Release Research (Publication) COVID-19 Infectious Disease Ott Lab
ABC7 News—As Omicron BA.4 and BA.5 variants overtake previous coronavirus variants across the United States, Gladstone Associate Investigator Nadia Roan, PhD, explains that their success may owe both to their ability to escape our immune system and to their accelerated replication rate. She suggests that more effort should be made to block infection at the level of the airways, the virus's entry point into our body.
Gladstone Experts COVID-19 Roan Lab
San Francisco Chronicle—A year has passed since California dropped most public health restrictions related to COVID-19, but the pandemic isn’t over. Senior Investigator Warner Greene notes that the virus is still spreading effectively, and people can be infected repeatedly with different subvariants.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
San Francisco Chronicle—A study in the Mission District of San Francisco tracked how COVID-19 symptoms have changed over the course of the pandemic. Gladstone virologist Nadia Roan explains that the Omicron variant infects the upper respiratory tract and triggers a localized immune response, which may in part explain why individuals infected during the Omicron wave were less likely to experience severe illness.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
